






News on Kathryn E. Falberg


























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology















                                Person                            


                                    Kathryn E. Falberg                                    ▼





                                Topic                            


                                    All Topics                                    ▼








Organizations

                                Find news about organizations
                            





Alumni

                                Find news on alumni of any org
                            





Industries

                                Find news on a particular market
                            





Your Contacts

                                Find news on your contacts
                            








Sign up for free daily alerts on this feed:











By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


















Follow




                            Change Feed
                        


Kathryn E. Falberg











Kathryn E. Falberg is no longer serving in their board position at aTyr Pharma, Inc.


                                June 27, 2017                                 • 
                                RelSci Data Update                            










Axovant Sciences Announces Fiscal Year-End Financial Results and Corporate Updates


                                June 13, 2017                                 • 
                                PR Newswire                            


                                  ... President and Chief Operating Officer of Axovant Sciences, Inc. In addition, Kathryn E. Falberg and W. Anthony Vernon were appointed as two new members of ...
                                









UroGen Pharma Welcomes New Board Member Kate Falberg


                                April 24, 2017                                 • 
                                GlobeNewswire                            


                                  ... needs in the field of uro-oncology, announced today the appointment of Kathryn "Kate" Falberg to its Board of Directors, effective immediately. Ms. Falberg will also ...
                                









Axovant Sciences Announces Appointment of Dr. David Hung as Chief Executive Officer and Expansion of Board of Directors


                                April 10, 2017                                 • 
                                PR Newswire                            


                                  ... appointment of two new members to the company's Board of Directors. Kathryn ("Kate") E. Falberg and William Anthony ("Tony") Vernon have joined as independent directors. ...
                                









Kathryn E. Falberg purchased $2.07M worth of shares in The Trade Desk, Inc. in November 2016


                                December 8, 2016                                 • 
                                RelSci Data Update                            










Trade Desk looks to break ad tech IPO silence


                                August 23, 2016                                 • 
                                The Deal Pipeline                            


                                  ... with president and CEO Jeff T. Green, COO Robert D. Perdue, Kathryn E. Falberg, Thomas Falk, Juan N. Villalonga (designated by Highwind) and David B. ...
                                









The Trade Desk, Inc. Welcomes Kate Falberg to Its Board of Directors


                                August 18, 2016                                 • 
                                Marketwired                            


                                  ... Inc., a global technology platform for buyers of advertising, today announced that Kate Falberg has joined its board of directors. Falberg, who began her career ...
                                









BioMarin Appoints Two BioPharmaceutical Veterans to Board of Directors, Willard Dere, M.D. and Kathryn E. Falberg


                                July 18, 2016                                 • 
                                GlobeNewswire                            


                                  ... former Senior Vice President in Research and Development at Amgen and Kathryn E. Falberg, former Chief Financial Officer of Jazz Pharmaceuticals and Amgen. "We are ...
                                









Allergen Research Corporation Announces New CFO Warren DeSouza and Board of Directors Audit Committee Chair Kate Falberg


                                April 21, 2015                                 • 
                                Business Wire                            


                                  ... functions. Warren DeSouza has joined ARC as Chief Financial Officer, and Kathryn "Kate" Falberg has joined the ARC Board of Directors as Chair of the ...
                                









Ariosa Diagnostics Welcomes New Board Member Kate Falberg


                                April 30, 2014                                 • 
                                PR Newswire                            


                                  ... New Board Member Kate Falberg . Ariosa Diagnostics Welcomes New Board Member Kate Falberg. SAN JOSE, Calif., April 30, 2014 /PRNewswire/ -- Ariosa Diagnostics, maker ...
                                









Jazz Pharmaceuticals Announces Management Change


                                February 25, 2014                                 • 
                                PR Newswire                            


                                  ... Announces Management Change . Jazz Pharmaceuticals Announces Management Change. Chief Financial Officer Kathryn Falberg to Step Down; Matthew Young Appointed CFO DUBLIN, Feb. 25, 2014 ...
                                









Jazz Deal for Gentium Shows Benefits of Inversions


                                December 20, 2013                                 • 
                                The New York Times Blogs(DealBook)                            


                                  ... into our international the tax structure," said Jazz's chief financial officer, Kathryn E. Falberg. "So we certainly think that this does leverage the fact that ...
                                









Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events


                                May 13, 2013                                 • 
                                PR Newswire                            


                                  ... on Tuesday, May 21, 2013 at 9:30 a.m. EDT/2:30 p.m. IST. Kathryn E. Falberg, executive vice president and chief financial officer, will provide a business ...
                                









Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March


                                February 27, 2013                                 • 
                                PR Newswire                            


                                  ... MA on Wednesday, March 6, 2013 at 8:40 a.m. EST/1:40 p.m. GMT. Kathryn Falberg, executive vice president and chief financial officer, will provide a business ...
                                









Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March


                                February 27, 2013                                 • 
                                PR Newswire                            


                                  ... MA on Wednesday, March 6, 2013 at 8:40 a.m. EST/1:40 p.m. GMT. Kathryn Falberg, executive vice president and chief financial officer, will provide a business ...
                                







Related News Feeds






Jazz Pharmaceuticals Plc







Pharmaceuticals







Board and Executive Moves in Pharmaceuticals







Alumni of UCLA Anderson School of Management

























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink



 






Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!


Start My Free Trial  ➤










 Industry:




 Select a Topic:



 Keyword:



Go  ➤









 Find an Organization:






 Select a Topic:




 Keyword:




Go  ➤









 Find a Person:






 Select a Topic:




 Keyword:




Go  ➤









 Name of a School:







 Or Name of an Organization:









 Select a Topic:




 Keyword:




Go  ➤








Thank you. You are now subscribed.Please wait for the page to refresh...










You are now subscribed to this feed.










You have unsubscribed to this feed.










Thank you. You can now subscribe to more RelSci news feeds.










 To subscribe to more than one feed, please enter a password.




 Please confirm your password



Go  ➤








You've found a premium RelSci Pro feature!



Follow News On Your Contacts

Upgrade to RelSci Pro now to easily sync your contacts and stay in the know on the news about the people important to you.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now








You've found a premium RelSci Pro feature!



Search News On Keywords

Curate your news even further with the ability to filter feeds based on specific keywords mentioned in the articles.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now













Industries

                        Find news on a particular market
                    





People

                        Find news about people
                    





Organizations

                        Find news about organizations
                    





Alumni

                        Find news on alumni of any org
                    





Your Contacts

                        Find news on your contacts
                    












                Free Daily Alerts
            


                Sign up for free daily alerts on this feed
            




Sign Up ➤

                    By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions




                Already have an account?  Click here to login.















Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤






















Kathryn E. Falberg appointed to BioMarin Pharmaceutical Inc. Board.
























Skip to main content










Login
 Username *
 Password *


GO >
Forgot password?  Not a Subscriber? 

















Search form
Search











Toggle navigation






















 













Ms. Kathryn E. FalbergFalberg served in several CFO roles, including at Amgen Pharmaceutical and, most recently, Jazz Pharmaceuticals. She currently is a director of Aimmune Therapeutics and Medivation Inc.2016 Fourth QuarterAdded to: BioMarin Pharmaceutical Inc. - San Rafael, CABioMarin products address serious diseases and medical conditions. Revenues are $924 million.















 















 










	Halozyme Therapeutics - Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors





























































E-mail this page












Homepage»Investors»News Releases»News Releases Details







View All News Releases

Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors

Share This







05/16/2007

Download this Press Release?()


SAN DIEGO, May 16 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc.
(Nasdaq: HALO - News), a biopharmaceutical company developing and commercializing
recombinant human enzymes, today announced that Randal J. Kirk and Kathryn E.
Falberg have been named to its Board of Directors.  Mr. Kirk was Founder,
Chairman of the Board, President, and CEO of New River Pharmaceuticals, Inc.
(Nasdaq: NRPH - News), which recently sold to Shire plc for $2.6 billion.  Ms.
Falberg is the former CFO of Amgen."We are thrilled to welcome RJ and Kate to our Board of Directors," said
Jonathan Lim, MD, Halozyme's President and CEO.  "Their addition to our Board
is timely, as Halozyme enters into this exciting period of growth and
transformation into an innovation-driven company with a pipeline of its own
products.  RJ brings over 20 years of successful management, financial, and
entrepreneurial experience to Halozyme.  He has been an incredibly supportive
shareholder and we welcome his wisdom and experience to our Board.  Kate is a
very experienced and talented finance executive, having served as CFO at
Amgen, Applied Magnetics, and Inamed.  Her many years of strategic and
financial experience helping manage growth at Amgen will serve us very well."Mr. Kirk has over 20 years of experience in the health care industry.
Previously, Mr. Kirk co-founded General Injectables & Vaccines, Inc. (GIV), a
pharmaceutical distributor, in 1983 and served as Chairman of the board of GIV
prior to the sale of that company in 1998.  Mr. Kirk served as a member of the
board of directors of Scios, Inc. (previously traded on Nasdaq and acquired by
Johnson & Johnson for $2.4 billion) between February 2000 and May 2002.  Mr.
Kirk also currently serves as Senior Managing Director of Third Security, LLC,
an investment management firm founded by Mr. Kirk.  In addition, he has served
as a member of the board of directors of Clinical Data, Inc. since September
2002, and as chairman of its board since December 2004.  He has served on the
board of directors of the Radford University Foundation, Inc. since September
1998, the Virginia Bioinformatics Institute Policy Advisory Board since March
2004, and the Board of Visitors of Radford University since July 2003.  He
serves on a number of other foundations, as well.  Mr. Kirk received his B.A.
in Business from Radford University and his J.D. from the University of
Virginia.Ms. Falberg has over 23 years of financial experience.  Ms. Falberg joined
Amgen, a global biotechnology company, in 1995 as Treasurer, and advanced
through a series of positions of increasing responsibility, culminating in her
appointment as Senior Vice President, Finance, and Chief Financial Officer in
1998.  At Amgen, over a period of almost seven years, Ms. Falberg played a key
role in shaping strategy as the company grew from $1.6 billion to $4.0 billion
in revenues, and from $7 billion to $70 billion in market capitalization.
Prior to Amgen, Ms. Falberg served as Vice President, Chief Financial Officer
and Treasurer of Applied Magnetics Corporation.  After her retirement from
Amgen, she was a consultant to Inamed, a medical device company (previously
traded on the Nasdaq and acquired by Allergan for $3.2 billion), and briefly
served as its interim Chief Financial Officer.  She has served on the board of
directors of VISX, Human Genome Sciences, and Fresh Del Monte Produce.  Ms.
Falberg received her M.B.A. and her B.A. in Economics from the University of
California, Los Angeles.About Halozyme Therapeutics, Inc.Halozyme is a biopharmaceutical company developing and commercializing
recombinant human enzymes for the drug delivery, palliative care, oncology,
and infertility markets.  The company's portfolio of products is based on
intellectual property covering the family of human enzymes known as
hyaluronidases.  The company's Enhanze(TM) Technology is a novel drug delivery
platform designed to increase the absorption and dispersion of biologics.  In
addition, the company has received FDA approval for two products: Cumulase®
and Hylenex, for use as an adjuvant to increase the absorption and dispersion
of other injected drugs and fluids.  The Company also has a number of
different enzymes in its portfolio that are targeting significant areas of
unmet need.Safe Harbor StatementIn addition to historical information, the statements set forth above
include forward-looking statements (including, without limitation, statements
concerning our strategy and vision) that involve risk and uncertainties that
could cause actual results to differ materially from those in the
forward-looking statements.  The forward-looking statements are also
identified through use of the words "believe," "enable," "may," "will,"
"could," "intends," "estimate," "anticipate," "plan," "predict," "probable,"
"potential," "possible," "should," "continue," and other words of similar
meaning.  Actual results could differ materially from the expectations
contained in forward-looking statements as a result of several factors,
including regulatory approval requirements and competitive conditions.  These
and other factors that may result in differences are discussed in greater
detail in the company's reports on Forms 10-K, 10-Q, and other filings with
the Securities and Exchange Commission.    Halozyme Contact                  Investor Relations Contact
    David A. Ramsay                   Don Markley
    Chief Financial Officer           Lippert/Heilshorn & Associates
    (858) 794-8881                    (310) 691-7100
    dramsay@halozyme.com              dmarkley@lhai.com

                                      Media Contacts
                                      Karen Sparks / Joleen Schultz
                                      Mentus
                                      (858) 455-5500, x275/x215
                                      karen@mentus.com
                                      jschultz@mentus.com

Source:
Halozyme Therapeutics, Inc.












Useful Links

Home
|
About Us
|
Investors
|
Careers
|
Clinical Trials
|
Contact Us






Contact Info





Office:
Halozyme
                     11388 Sorrento Valley Road
                     San Diego, CA 92121
                     Phone: 858.794.8889
 info@halozyme.com





















Normal



Recent News




July 13, 2017
Initiation Of Clinical Trial Collaboration Evaluating Halozyme's PEGPH20 In Combination With Anti-PDL1 Immunotherapy






July 10, 2017
Halozyme To Host Second Quarter 2017 Financial Results Conference Call






June 28, 2017
Halozyme Phase 2 Data In Advanced Pancreas Cancer Presented At European Society For Medical Oncology Symposium

















        Copyright © 2015-2017 . Halozyme, Inc.  All rights reserved. All trademarks belong to their respective owners.
    



Powered By Q4 Inc. 4.5.0.5




Notice 
You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.
Ok


















 of Biomarin Pharmaceutical Inc Board of Directors

















 












Welcome!















Company News
Company Site
Premium
Log In


 



















Membership
Home
Portfolio
Stocks
Bonds
Funds
ETFs
CEF
Markets
Tools
Real Life Finance
Discuss





Investing Ideas


Fund Analyst Picks
Picks by Category
Fund Pick Performance
Picks & Pans E-Newsletter
Fund Spy Column
Fund Spy Book
Bond Squad
Fund Video Reports
FundInvestor Newsletter
ETF Investing
Fund Family Experts



Fund Reports


All Fund Analyst Reports
Fund Stewardship Reports



Fund Ratings


Highest-Rated Value
Highest-Rated Growth
Highest-Rated Large-Cap
Highest-Rated Mid-Cap
Highest-Rated Small-Cap
Foreign Fund Standouts
Star Rating Performance
Rating Methodology



Fund Performance


Top 1-Month Performers
Top YTD Performers
Top 1-Year Performers
Top 3-Year Performers
Top 5-Year Performers
Fund Category Returns
Biggest Daily NAV Changes
Closed-End Funds
Exchange-Traded Funds
Quarterly Market Outlook



Fund Screeners


Basic Screeners
Fund Screener
Long-Term Winners
Solid Small-Growth Funds
Conservative Bond Funds

Premium Screeners
Premium Fund Screener
Index Funds
Hidden Gems
Lower-Risk Foreign Funds


Video Center
 
 

 



 



Biomarin Pharmaceutical Inc
 BMRN


Add to PortfolioGet E-mail AlertsPrint This PagePDF ReportData QuestionQuoteChartStock AnalysisPerformanceKey RatiosFinancialsValuationInsidersOwnershipFilingsBondsOverviewExecutive CompensationInsider ActivityKey ExecutivesBoard of DirectorsCommittees
 


Board of Directors
                > 
            
, 



Profile
Connections






Biography









Board Membership



Company Name
Board Member Since
Board Committees







 is connected to 26 Board Members.See list of all Board Connections.

 


  







We value your feedback. Let us know what you think.













 


Site Directory
Site Map
Our Products












 



 



 




Corrections
Help
Advertising Opportunities
Licensing Opportunities
Glossary
RSS
Mobile Portfolio
Affiliate
Careers 
 


International Sites:
        	Australia
Canada
China
France
Germany
Hong Kong
Italy
The Netherlands
Norway
Spain
U.K.
Switzerland

 




Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry



Premium Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Premium Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



Premium ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Popular Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Popular Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry




Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.
        © Copyright  Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. Russell 2000 quote is 10 minutes delayed.
 


 













   Kathryn Falberg | BioMarin Pharmaceutical Inc. | ZoomInfo.com


Kathryn E Falberg - Topanga, CA | Intelius



























Sign In



We found Kathryn E Falberg in Topanga, CA


Kathryn E Falberg

                                                            Intelius found that Kathryn E Falberg  is  a female from Topanga, CA.  We have connected them to
                3 addresses,
                2 phones,
                and 1 relative or associate.
         






Get Report Now

Kathryn Has Lived In

Topanga, CA
Brisbane, CA
West Hills, CA

Kathryn's Relatives

Predovich Falberg







Kathryn E Falberg



GenderFemale



Professional Status
Director at Aimmune Therapeutics, Inc.



Get Report Now










Want to know more about Kathryn? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Kathryn, or use our people search engine to find others.
Get Background Check on Kathryn E Falberg
Get a Criminal Check on Kathryn E Falberg
Get a Public Record Report on Kathryn E Falberg
Get a People Search Report on Kathryn E Falberg


Kathryn E Falberg's Contact Information
Known Cities Lived In
Find out where Kathryn E Falberg has lived as well as Kathryn E Falberg's phone numbers and email addresses.




Kathryn E Falberg Has Lived in 1 States
California Address for Kathryn E Falberg


3128 N S***** P***** D* 

Topanga, CA


Has Lived In

Topanga, CA
Brisbane, CA


Get Full Address Report










Phone Numbers Associated with Kathryn E Falberg

(818) ***-**** - West Hills, CA 
(650) ***-**** - Brisbane, CA 


Get Full Phone Report



Email Addresses Associated with Kathryn E Falberg



Get Email Report




Kathryn E Falberg's Professional Information
Information regarding Kathryn E Falberg's professional history.  Find out previous places Kathryn E Falberg has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Kathryn E Falberg Has Worked at 1 Place
Company: Aimmune Therapeutics, Inc.
               Title: Director
Kathryn E Falberg's Experience
Title: Director
               Company: Aimmune Therapeutics, Inc.
Job Details
               Aimmune Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The company's Characterized Oral Desensitization ImmunoTherapy (CODIT) system, an approach to oral immunotherapy (OIT), uses rigorously characterized biologic product candidates with gradual, controlled up-dosing protocols to obtain clinically meaningful desensitization to food allergens. Aimmune's first CODIT product, AR101 for the treatment of peanut allergy, has received the FDA's Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials.
Additional Professional Information on Kathryn E Falberg

 See Kathryn E Falberg's LinkedIn Profile



Kathryn E Falberg's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Kathryn E Falberg


Kathryn E Falberg's known Social Networks And Potential Email Matches

Find all of Kathryn E Falberg's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Kathryn Falberg
Username Matches

                  KathrynFalberg
                  FalbergKathryn
                  Kathryn.Falberg
                  Falberg.Kathryn
                  Kathryn_Falberg
                  Falberg_Kathryn
                  Kathryn-Falberg
                  Falberg-Kathryn
                  KFalberg
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
K Falberg







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.













FALBERG KATHRYN E: Form 4 Insider Trading History | Insider Insights



 







insider data searchcompliance searchprospect searchmanage portfoliosnew portfoliomanage screensnew screen





Home

About

FAQ

Contact

Media Mentions

Money Management

Subscribe



 










Search









Free Insider Data

Latest Insider Filings
Top 20 Searches
Portfolio Alerts
Top Trades Email
Special Screens Reports



Subscription Insider Data

Insider Filing Search
Prospect Search
Insider Special Screens
Insider Portfolio Alerts
Subscribe To Data Module



Insider Newsletter

Get Latest Newsletter
Subscribe To Newsletter



Subscriber Sign In

Pre-Programmed Screens
Pre-Programmed Searches
Saved Client Screens
Saved Client Searches
Saved Client Dossiers
Subscribe Now
Sign In




















Search by Ticker
Search by Filer Name
Search by Company Name
Search by Input Date



















Transaction Types













 B
 AB
 JB*
 OB
 OE*
 OE


 S
 AS
 JS*
 OS
 OS*
 3








 JB


 JS







					Reduced Version of Subscription Insider Search







Check all filing types




Uncheck all filing types




Remove The Noise























        Free Insider
        Products
    

Insider Portfolio Alerts
Free real time insider alerts


Top Trade Alerts
Free insider trades intra-day


Special Screens Report
Free insider special screens report





	Our Input Date Search is an excellent tool to examine the latest insider trades for new long and short investment ideas, 
	but it is only available to paid subscribers.
	
Click Here to Subscribe

close window



	Feature available to paying subscribers only. Subscriber output is also not separated on different pages, 
	so that print outs and Excel downloads contain all of a search's information.
	
Click Here to Subscribe

close window















Detailed Insider History For:'FALBERG KATHRYN E'














click column headers to sort
#
View Form

Insider Statistics

T
N
H
M
S


Insider Title
Company Name
Ticker
Trans Type
Dollar Value
Shares Traded
Trans Date From
Trans Date To
Trans Price From
Trans Price To
Total Holdings
Delta % Owned
Owned
Other Info
SIC Code
SIC Sector
SIC Industry
SIC Sub-Industry
Input Date
1

6m2100%88%6
DIR
TRADE DESK INC
TTD
B
$961,154
20,000
---
6/15/17
---
$48.06
80,000
33.3
I
---
7370
Services
Business Services
 Services- Computer Programming, Data Processing, Etc.
6/16/17 - 4:07:21 pm
2

3m1100%14%6
DIR
AXOVANT SCIENCES LTD
AXON
JB*
$999,992
53,937
---
4/17/17
---
$18.54
53,937
New
D
---
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
4/19/17 - 4:07:30 pm
3

     
DIR
AXOVANT SCIENCES LTD
AXON
3
---
---
---
4/7/17
---
---
---
---
D
---
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
4/11/17 - 5:49:58 pm
4

6m2100%88%6
DIR
TRADE DESK INC
TTD
B
$867,664
20,000
---
3/1/17
---
$43.38
60,000
50.0
I
---
7370
Services
Business Services
 Services- Computer Programming, Data Processing, Etc.
3/3/17 - 4:42:50 pm
5

6m2100%88%6
DIR
TRADE DESK INC
TTD
B
$1,028,200
40,000
11/14/16
11/15/16
---
$25.49
40,000
New
D
---
7370
Services
Business Services
 Services- Computer Programming, Data Processing, Etc.
11/16/16 - 5:03:37 pm
6

6m2100%88%6
DIR
TRADE DESK INC
TTD
B
$1,039,600
40,000
---
11/14/16
---
$25.99
40,000
New
I
---
7370
Services
Business Services
 Services- Computer Programming, Data Processing, Etc.
11/16/16 - 5:03:37 pm
7

     
DIR
MEDIVATION INC
MDVN
JS
---
50,000
---
9/28/16
---
---
---
All
I
R
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
9/30/16 - 5:42:52 pm
8

     
DIR
MEDIVATION INC
MDVN
JS
---
32,742
---
9/28/16
---
---
---
All
D
R
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
9/30/16 - 5:42:52 pm
9

     
DIR
TRADE DESK INC
TTD
3
---
---
---
9/20/16
---
---
---
---
---
---
7370
Services
Business Services
 Services- Computer Programming, Data Processing, Etc.
9/20/16 - 5:18:17 pm
10

     
DIR
BIOMARIN PHARMACEUTICAL INC
BMRN
JB
---
2,640
---
7/15/16
---
---
2,640
New
D
A,R
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
9/1/16 - 6:24:40 pm
11

     
DIR
BIOMARIN PHARMACEUTICAL INC
BMRN
JB
---
3,300
---
7/15/16
---
---
3,300
New
D
R
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
7/19/16 - 5:22:37 pm
12

     
DIR
BIOMARIN PHARMACEUTICAL INC
BMRN
3
---
---
---
7/15/16
---
---
---
---
---
---
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
7/19/16 - 5:21:13 pm
13

     
DIR
MEDIVATION INC
MDVN
JB
---
2,972
---
6/22/16
---
---
32,742
10.0
D
R
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
6/23/16 - 8:40:13 pm
14

     
DIR
HALOZYME THERAPEUTICS INC
HALO
JB
---
20,202
---
5/4/16
---
---
358,253
6.0
D
R
2836
Manufacturing
Chemicals And Allied Products
 Biological Products, (No Disgnostic Substances) 
5/6/16 - 4:47:56 pm
15

1y3100%73%6
DIR
HALOZYME THERAPEUTICS INC
HALO
OB
$49,400
10,000
---
1/13/16
---
$4.94
338,051
3.0
D
---
2836
Manufacturing
Chemicals And Allied Products
 Biological Products, (No Disgnostic Substances) 
1/14/16 - 7:06:38 pm
16

     
DIR
HALOZYME THERAPEUTICS INC
HALO
JB
$103,700
10,000
---
1/13/16
---
$10.37
328,051
3.1
D
---
2836
Manufacturing
Chemicals And Allied Products
 Biological Products, (No Disgnostic Substances) 
1/14/16 - 7:06:38 pm
17

6m10%-34%6
DIR
AIMMUNE THERAPEUTICS INC
AIMT
JB*
$400,000
25,000
---
8/11/15
---
$16.00
94,894
35.8
D
---
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
8/11/15 - 11:33:23 am
18

     
DIR
AIMMUNE THERAPEUTICS INC
AIMT
3
---
---
---
8/5/15
---
---
69,894
---
D
---
2834
Manufacturing
Chemicals And Allied Products
 Pharmaceutical Preparations
8/5/15 - 6:34:46 pm









Amazon.com Widgets











Subscribe

Search

Screens

Alerts

Newsletter

Money Management

Free Stuff




Home

About

FAQ

Contact

Disclaimer & Terms Of Use

Privacy

Media Mentions

Transaction Codes


© 2017 InsiderInsights.com



 
















 





LIFE Kathryn E. Falberg Insider Trades for aTyr Pharma Inc.


































Bulletin

Dow ends lower as General Electric falls; Nasdaq snaps 10-session winning streak »
        




Investor Alert







New York Markets After Hours



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































aTyr Pharma Inc.

                  NASDAQ: LIFE
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

aTyr Pharma Inc.



Market closed
 --Real time quotes
Jul 21, 2017, 3:59 p.m.


LIFE

/quotes/zigman/49862350/composite


$
3.25




Change

-0.15
-4.41%

Volume
Volume 25,058
Real time quotes








/quotes/zigman/49862350/composite
Previous close

$
			3.40
		


$
				3.25
			
Change

-0.15
-4.41%





Day low
Day high
$3.25
$3.50










52 week low
52 week high

            $2.10
        

            $4.45
        


















Insider Activity


Individual




Kathryn E. Falberg



Ms. Kathryn E. Falberg is Independent Non-Employee Director at Aimmune Therapeutics, Inc., Independent Director at aTyr Pharma, Inc., Independent Director at Medivation, Inc. and Chairman at Halozyme Therapeutics, Inc. She is on the Board of Directors at Aimmune Therapeutics, Inc., aTyr Pharma, Inc., Medivation, Inc. and ESS Technology, Inc. Ms. Falberg was previously employed as Chief Financial Officer & Senior Vice President by Azur Pharma Ltd., Chief Financial Officer, Director & Executive VP by Jazz Pharmaceuticals, Inc., Independent Director by QLT, Inc., Chief Operating & Financial Officer by ARCA biopharma, Inc., Chief Financial Officer & Executive Vice President by Jazz Pharmaceuticals Plc, President by Canyon Capital & Consulting, Inc., Chief Financial Officer by INAMED Corp., Chief Financial Officer & Senior VP-Strategy by Amgen, Inc., and Chief Financial Officer, Treasurer & VP by Applied Magnetics Corp. She also served on the board at Ariosa Diagnostics, Inc., Human Genome Sciences, Inc. and Fresh Del Monte Produce, Inc. She received her undergraduate degree from the University of California, Los Angeles and an MBA from the University of California, Los Angeles.



Transactions


Date
Shares
Transaction
Value








        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. John K. Clarke 
Chairman




Dr. John D. Mendlein 
Chief Executive Officer & Director




Mr. John T. Blake 
Vice President-Finance




Dr. David John King 
Senior Vice President-Research




Dr. Sanjay  Shukla 
Chief Medical Officer




Dr. Ashraf  Amanullah 
Vice President-Manufacturing




Dr. Sanuj K. Ravindran 
Chief Business Officer




Dr. Melissa  Ashlock 
Senior VP-Translational Medicine & Therapeutics




Dr. Andrew B. Cubitt 
Vice President-Product Protection




Mr. Grove  Matsuoka 
SVP-Product Programs & Planning




Mr. Timothy P. Coughlin 
Director




Mr. Jeffrey S. Hatfield 
Director




Dr. Mark Alan Goldberg 
Director




Ms. Nancy Denyes Krueger 
Secretary & Vice President-Legal Affairs




Dr. Amir H. Nashat 
Independent Director




Dr. Paul R. Schimmel 
Independent Director




Dr. Jim C. Blair 
Independent Director




Dr. Srinivas  Akkaraju 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




4:11 PM EDT
July 21, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
4:10pTrump Today: President says he shook up communications team to ‘make America great again’
4:10pNolan’s cinematic vision in ‘Dunkirk’ is Hollywood’s best defense against Netflix
4:09pJohn McCain is a war hero — but think twice before saying he’s ‘battling’ cancer 
4:07pU.S. stocks close lower as shaky GE outlook ends week
4:07pMicrosoft is challenging Amazon for cloud throne
4:06pDow books a 0.3% weekly loss 
4:05pFor the week, the S&P 500, Nasdaq booked their third straight gains
4:05pS&P 500 logs a weekly rise of 0.5%; Nasdaq closes wraps up with a weekly climb of 1.2%
4:03pNasdaq Composite closes down little-changed but in the red
4:02pS&P 500 ends flat at 2,472; Dow closes off 0.2% 
4:01pBREAKINGNasdaq halts 10-session win streak as tech rally cools
4:01pStock market finishes slightly lower to end the week as GE earnings weigh
3:44pSean Spicer quits as White House press secretary over Scaramucci hire 
3:42pDo You Tip Your Uber Driver?
3:33pOil ends at a more than 1-week low with OPEC output expected to rise
3:29pS&P 500, Nasdaq poised for weekly gains even as stocks retreat record range
3:21pEuro rallies to 2-year high as hawkish view on ECB dominates
3:08pFed sets 2020 goal for faster payment systems
2:58pWhite House briefs reporters after Spicer quits as press secretary: live blog
2:56pHow real-estate TV shows determine what buyers look for in a house
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft






















Loading Your Search Results - PeopleLooker.com























Updating Data On {{nameize fn}}{{#if mi}} {{nameize mi}}{{/if}} {{nameize ln}} {{#validLocation city}}in {{city}}{{#validLocation state}},{{/validLocation}} {{/validLocation}}{{#validLocation state}}{{#unless city}}in {{/unless}}{{uppercase state}}{{/validLocation}}
Important! PeopleLooker uses real public records. The information may be surprising.












Less than 30 seconds remaining


Continue to Results 







Now
We look up all people named {{nameize fn}} {{nameize ln}}.




Next
You pick which one you're looking for.




Then
We search our database for info on them.




Hooray!
You get your report!












Where does {{nameize fn}}{{#if mi}} {{uppercase mi}}{{/if}} {{nameize ln}}
live?
Please help us narrow down your search











All States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





I'm not sure














Please enter a full name
Please help us narrow down your search







First Name:

Please Enter First Name


Last Name:

Please Enter Last Name












































People Searching Made Easy! | PeopleLooker
































Looking to Find Out About Someone?

Find information you may not get on Google.












State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





Search





We respect your privacy.













We've run over


1,000,000


background reports!
Successful background reports!









Access Premium Public Records

Quickly search public records that could otherwise take you weeks or months
to collect. Find friends, relatives, neighbors, or even yourself. Comprehensive
people search reports may contain:




Names
Criminal Records
Date of Birth




Phone Numbers
Addresses
Court Records




Relatives
Email Addresses
Much More!




Names
Criminal Records
Date of Birth
Relatives
Email Addresses




Phone Numbers
Addresses
Court Records
Much More!







The New Way to Find People
More than a regular search engine.

It's the quick and easy way to look people up. Do a deep public record
search to uncover the important information you're looking for. Now you'll
never have to search someone on google again.





































People Searching Made Easy! | PeopleLooker
































Looking to Find Out About Someone?

Find information you may not get on Google.












State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





Search





We respect your privacy.













We've run over


1,000,000


background reports!
Successful background reports!









Access Premium Public Records

Quickly search public records that could otherwise take you weeks or months
to collect. Find friends, relatives, neighbors, or even yourself. Comprehensive
people search reports may contain:




Names
Criminal Records
Date of Birth




Phone Numbers
Addresses
Court Records




Relatives
Email Addresses
Much More!




Names
Criminal Records
Date of Birth
Relatives
Email Addresses




Phone Numbers
Addresses
Court Records
Much More!







The New Way to Find People
More than a regular search engine.

It's the quick and easy way to look people up. Do a deep public record
search to uncover the important information you're looking for. Now you'll
never have to search someone on google again.





































People Searching Made Easy! | PeopleLooker
































Looking to Find Out About Someone?

Find information you may not get on Google.












State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





Search





We respect your privacy.













We've run over


1,000,000


background reports!
Successful background reports!









Access Premium Public Records

Quickly search public records that could otherwise take you weeks or months
to collect. Find friends, relatives, neighbors, or even yourself. Comprehensive
people search reports may contain:




Names
Criminal Records
Date of Birth




Phone Numbers
Addresses
Court Records




Relatives
Email Addresses
Much More!




Names
Criminal Records
Date of Birth
Relatives
Email Addresses




Phone Numbers
Addresses
Court Records
Much More!







The New Way to Find People
More than a regular search engine.

It's the quick and easy way to look people up. Do a deep public record
search to uncover the important information you're looking for. Now you'll
never have to search someone on google again.





































People Searching Made Easy! | PeopleLooker
































Looking to Find Out About Someone?

Find information you may not get on Google.












State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





Search





We respect your privacy.













We've run over


1,000,000


background reports!
Successful background reports!









Access Premium Public Records

Quickly search public records that could otherwise take you weeks or months
to collect. Find friends, relatives, neighbors, or even yourself. Comprehensive
people search reports may contain:




Names
Criminal Records
Date of Birth




Phone Numbers
Addresses
Court Records




Relatives
Email Addresses
Much More!




Names
Criminal Records
Date of Birth
Relatives
Email Addresses




Phone Numbers
Addresses
Court Records
Much More!







The New Way to Find People
More than a regular search engine.

It's the quick and easy way to look people up. Do a deep public record
search to uncover the important information you're looking for. Now you'll
never have to search someone on google again.



























kathryn falberg - WOW.com - Web Results










AOL Search
Skip over navigation

















Search the Web



























Web





Images


Images




Reference


Reference










We Found Kathryn Falberg | beenverified.com



Ad
 ·
www.beenverified.com



1) Kathryn Falberg's Photo 2) Address 3) Phone & More. Find Now.





People Search



Search By Name



Search by Email




Best Background Check



Social Media



Get Contact Information





We Found Kathryn Falberg | peoplelooker.com



Ad
 ·
www.peoplelooker.com



1) Kathryn Falberg's Phone 2) Address 3) Age & More. Search Free!





Uncover Potential Relatives



Location History



Photos & Videos



Email Address





Searches related tokathryn falberg



kate falberg




Web Results

Kathryn E. Falberg: Executive Profile & Biography - Bloomberg

https://www.bloomberg.com/research/stocks/private/person.asp?...


Ms. Kathryn E. Falberg, also known as Kate, served as Consultant of Allergan Medical. Ms. Falberg has over 23 years of financial experience with companies ...


Kate Falberg | LinkedIn

https://www.linkedin.com/in/kate-falberg-7809683


View Kate Falberg’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Kate Falberg discover inside ...


Kathryn E. Falberg - Executive Bio & Compensation History

executives.findthecompany.com/l/83245/Kathryn-E-Falberg


Find compensation and employment information for Kathryn E. Falberg (Fresh Del Monte Produce), including salary, stock awards, and previous employers.


Kathryn E. Falberg - Executive Bio, Compensation History ...

people.equilar.com/bio/kathryn-falberg-jazz-pharmaceuticals/salary/...


View Kathryn E. Falberg, Board Member at BioMarin Pharmaceutical Inc., San Rafael, CA, executive profile on Equilar Atlas to see current salary at BioMarin ...


Kathryn Kate Falberg Profiles | Facebook

https://www.facebook.com/public/Kathryn-Kate-Falberg


View the profiles of people named Kathryn Kate Falberg. Join Facebook to connect with Kathryn Kate Falberg and others you may know. Facebook gives people...


Kathryn E Falberg, 56 - Topanga, CA | MyLife.com ...

https://www.mylife.com/kathryn-falberg/e5208667962


AKA: K Gehrke, Kate Falberg, Kate E Falberg, Kathryn Gehrke, Kathryn E Falberg, Kathryn E Falberg-gehrke, Kathryn E Gehrke, Kathryn Elizabeth Falberg, Kathryne Gehrke


Kathryn E. Falberg - Executive Vice President and Chief ...

https://www.crunchbase.com/person/kathryn-e-falberg


Kathryn Falberg was appointed our Executive Vice President and Chief Financial Officer in March 2012. She served as our Senior Vice President and Chief Financial ...


Kathryn Falberg | Jazz Pharmaceuticals | Email, CFO ...

https://app.lead411.com/Kathryn_Falberg_1260254.html


Kathryn Falberg's email address, phone numbers, linkedin account, wiki may be included in Jazz Pharmaceuticals's Lead411 profile and other Jazz Pharmaceuticals email ...


Kathryn Falberg Profiles in AZ, CA, FL, HI, MA, NY, and PA ...

https://www.bizapedia.com/people/kathryn-falberg.html


Kathryn Falberg is associated with 12 companies in Boston MA, Honolulu HI, Los Angeles CA, New York NY, Novato CA, Palo Alto CA, Palo CA, Philadelphia PA, Ph...


People Search | Whitepages

www.whitepages.com/name/Kathryn-Falberg


3 results for Kathryn Falberg 3 results found Filter. Show more premium results Hide Premium Results. Kathryn E Falberg. Age 55-59; ... Kathryn E Falberg. Age ...










We Found Kathryn Falberg | beenverified.com



Ad
 ·
www.beenverified.com



1) Kathryn Falberg's Photo 2) Address 3) Phone & More. Find Now.





People Search



Search By Name



Search by Email




Best Background Check



Social Media



Get Contact Information





We Found Kathryn Falberg | peoplelooker.com



Ad
 ·
www.peoplelooker.com



1) Kathryn Falberg's Phone 2) Address 3) Age & More. Search Free!





Uncover Potential Relatives



Location History



Photos & Videos



Email Address




Searches related tokathryn falberg



kate falberg




12345Next














Search the Web

















© AOL Inc. All Rights Reserved.Privacy
 | Terms of Use
 | About our Ads
 | Preferences
 | Contact Us
 | Powered by Bing™

Part of the AOL Search Network.








